Grown Rogue International AI Stock Analysis
Want to see TSE:GRIN full AI Analyst Report?
Grown Rogue International (GRIN) AI Stock Analysis
Grown Rogue International
(CNQX:GRIN)
The score is primarily constrained by inconsistent profitability, negative free cash flow, increased leverage, weak technical positioning, and a negative P/E ratio. Operational execution, expansion progress, and raised guidance provide meaningful upside support but do not fully offset the financial and market risks.
Grown Rogue International (GRIN) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 86.23M
- Dividend Yield
- ―
- Average Volume (3M)
- 27.74K
- Price to Earnings (P/E)
- -21.7
- Beta (1Y)
- 1.30
- Revenue Growth
- 34.29%
- EPS Growth
- -307.69%
- Country
- Canada
- Employees
- 204
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Grown Rogue International Business Overview & Revenue Model
Company Description
Grown Rogue International Inc., operating through its various subsidiaries, specializes in the cultivation and distribution of diverse cannabis products across the United States. Its comprehensive product portfolio features an assortment of cannabis...
How the Company Makes Money
GRIN makes money primarily by producing cannabis (cultivation) and converting harvested biomass into sellable products (post-harvest processing/manufacturing) that are sold into regulated markets. Key revenue streams include: (1) Wholesale cannabis s...
Grown Rogue International Earnings Call Summary
The call was overall positive: management reported record operational performance (notably in Michigan), clear progress on multi-state expansion (NJ, IL, MN), modest price recovery in Oregon, and demonstrated capital allocation discipline. Lowlights are largely operational/startup frictions, an ASP reporting distortion from a shake-based product in New Jersey, regulatory timing uncertainty in new states, and ongoing industry pricing volatility. The highlights — particularly the record cost and yield metrics, expanding capacity, and raised guidance supported by visibility — materially outweigh the manageable challenges discussed.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management guidance emphasized capacity buildouts and replicating Michigan-level efficiency: New Jersey is expected to reach full 16,000 sq ft flowering capacity (three additional flower rooms plus a mother room) by year‑end (100% of packaged flower sales this quarter and some bulk purchases to meet demand); Illinois had plants in June with first harvest expected in September and canopy expanding from an initial 5,000 sq ft to an approved 10,000 sq ft by year‑end; Minnesota plans to bring plants in August, harvest by year‑end and begin sales in Q1 2027. Operational targets call for matching Michigan’s record 90 grams/sq ft flower and $277/lb flower‑only cost (sub‑$200/lb full biomass), with management citing 90–100 g/sq ft and sub‑$300/lb flower as the new standard (sub‑$400–$500 and lower benchmarks cited as achievable), noting tech upgrades can be installed for low six‑figure costs; capital allocation aims to generate ~$0.75 of operating profit for every $1 invested after 12–18 months, the company reported Michigan excise tax as revenue, and it excluded a Yeti Ready‑to‑Roll SKU (shake normally ~$250/lb sold as ready‑to‑roll at ~ $1,000/lb) from flower ASP calculations.
Grown Rogue International Financial Statement Overview
Summary
Revenue growth and positive operating cash flow are offset by negative EBIT, a net loss, negative free cash flow, and rising debt relative to equity.
Income Statement
54NeutralBalance Sheet
52NeutralCash Flow
49Neutral| Breakdown | TTM | Mar 2026 | Oct 2023 | Jan 2023 | Oct 2021 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.86M | 22.15M | 21.83M | 17.76M | 9.38M | 4.24M |
| Gross Profit | 15.69M | 11.03M | 14.22M | 8.12M | 6.10M | 1.85M |
| EBITDA | 3.75M | 11.97M | 3.44M | 3.41M | 2.55M | -701.40K |
| Net Income | 320.93K | 6.35M | -533.04K | 447.46K | -1.01M | -3.15M |
Balance Sheet | ||||||
| Total Assets | 65.89M | 55.90M | 30.16M | 16.37M | 14.21M | 3.76M |
| Cash, Cash Equivalents and Short-Term Investments | 13.71M | 13.09M | 8.86M | 1.58M | 1.11M | 217.79K |
| Total Debt | 27.50M | 17.37M | 6.72M | 4.91M | 4.57M | 2.66M |
| Total Liabilities | 42.63M | 23.66M | 17.61M | 7.43M | 7.09M | 4.71M |
| Stockholders Equity | 16.85M | 30.67M | 11.56M | 6.93M | 5.09M | -911.64K |
Cash Flow | ||||||
| Free Cash Flow | -53.46K | 811.46K | 4.27M | 892.89K | -2.29M | -851.60K |
| Operating Cash Flow | 7.22M | 2.54M | 5.73M | 2.00M | -238.46K | -293.84K |
| Investing Cash Flow | -5.55M | -4.78M | -2.89M | -1.11M | -2.73M | -647.76K |
| Financing Cash Flow | 3.80M | 11.22M | 4.43M | -422.54K | 3.86M | 1.08M |
Grown Rogue International Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GRIN, the sentiment is Negative. The current price of 0.45 is below the 20-day moving average (MA) of 0.50, below the 50-day MA of 0.56, and below the 200-day MA of 0.54, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 35.55 is Neutral, neither overbought nor oversold. The STOCH value of 9.09 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GRIN.
Grown Rogue International Risk Analysis
Grown Rogue International disclosed 56 risk factors in its most recent earnings report. Grown Rogue International reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksGrown Rogue International Peers Comparison
Overall Rating
TSE:LOVE77Outperform
TSE:XLY76Outperform
TSE:GRIN52Neutral
TSE:JUSH40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | CAD 200.53M | 17.69 | 9.45% | ― | 14.66% | -33.72% | |
| 76Outperform | CAD 371.65M | 10.66 | 18.12% | ― | 18.79% | 10.74% | |
| 52Neutral | CAD 112.47M | -21.68 | -12.66% | ― | 34.29% | -307.69% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 40Underperform | CAD 121.82M | -1.54 | 40.14% | ― | 5.37% | 17.78% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:GRIN | Grown Rogue International | 0.45 | 0.00 | 0.00% | |
| TSE:JUSH | Jushi Holdings Inc | 0.61 | -0.03 | -4.69% | |
| TSE:XLY | Auxly Cannabis Group (Otc) | 3.55 | 1.31 | 58.48% | |
| TSE:LOVE | Cannara Biotech, Inc. | 2.01 | 0.39 | 24.07% |
Grown Rogue International Corporate Events
Grown Rogue Enters Illinois Market With Dwight Facility Relaunch
PositiveGrown Rogue International, a craft-focused cannabis producer specializing in high-quality flower and related products, has built its brand around genetics-driven cultivation and experienced grow teams. Rooted in Oregon’s Rogue Valley, the company tar...
Grown Rogue Launches Cannabis Cultivation Operations in Minnesota
PositiveGrown Rogue has begun cultivation at an affiliated licensed cannabis facility in Fridley, Minnesota, marking a significant step in its expansion into the state. Phase I includes about 8,000 square feet of flowering canopy across five rooms within a 1...
Grown Rogue Moves into New York Market with PharmaCann Asset Deal and $15 Million Financing
PositiveGrown Rogue International is entering the New York cannabis market through a planned acquisition of PharmaCann’s New York license and assets, including a large Hamptonburgh cultivation and manufacturing facility and four Verilife-branded dispensaries...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 03, 2026
